AJ

Asima Jillani

Active Director Director DIN 10279908
DIN 10279908 First appointment Aug 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Asima Jillani

Data last updated:

Asima Jillani is a Director at Globalmedics Private Limited (since 2026) and Director at Ammeaz International Private Limited (since 2023).

DIN 10279908
Primary Designation Director
First Appointment 16 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Globalmedics Private Limited U86201JK2026PTC018786
Director23 Feb 20262026Active
Ammeaz International Private Limited U47219JK2023PTC014946
Director16 Aug 20232023Active

Board colleagues of Asima Jillani

Directorship timeline

Open interactive timeline →
Ammeaz International Private Limited
Globalmedics Private Limited
Premium access

Shareholding and investment profile for Asima Jillani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asima Jillani

Asima Jillani currently holds 2 directorships: Globalmedics Private Limited (Director, since 23 Feb 2026); Ammeaz International Private Limited (Director, since 16 Aug 2023).

Asima Jillani was first appointed on 16 Aug 2023 as Director at Ammeaz International Private Limited. The most recent appointment on record is 23 Feb 2026 at Globalmedics Private Limited.

The current boards of Asima Jillani's companies include Amina Gowhar (Globalmedics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available